Cellular compartmentalization of phosphorylated eIF2α and neuronal NOS in human temporal lobe epilepsy with hippocampal sclerosis

Journal of the Neurological Sciences

Volumn 209, Issue 1-2, 2003, Pages 31-39

  Petrov, Theodor ^a   Rafols, José A ^a   Alousi, Sarah S ^a   Kupsky, William J ^a   Johnson, Robert ^a   Shah, Jagdish ^a   Shah, Aashit ^a   Watson, Craig ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Glia; Hippocampus; Immunocytochemistry; NADPH D; Neurons

Indexed keywords

CARBAMAZEPINE; INITIATION FACTOR 2; INITIATION FACTOR 2ALPHA; LAMOTRIGINE; NITRIC OXIDE SYNTHASE; PHENYTOIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE; TOPIRAMATE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CASE REPORT; CELL COMPARTMENTALIZATION; CELL LABELING; CONTROLLED STUDY; CYTOPLASM; DENTATE GYRUS; HIPPOCAMPAL SCLEROSIS; HIPPOCAMPUS; HISTOCHEMISTRY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIKARYON; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; SCLEROSIS; TEMPORAL LOBE EPILEPSY; TEMPORAL LOBECTOMY;

EID: 0037447742     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(02)00461-6     Document Type: Article

References (55)

1. Babb T.L., Brown W.J. Pathological findings in epilepsy. Engel J. Jr. Surgical treatment of the epilepsies. 1987;511-540 Raven Press, New York.
2. Margerison J.H., Corsellis J.A.N. Epilepsy and the temporal lobes. A clinical, electroencephalographic, neuropathological study of the brain in epilepsy with particular reference to the temporal lobes. Brain. 89:1966;499-530.
3. Falconer M.A., Serafetinides E.A., Corsellis J.A.N. Etiology and pathogenesis of temporal lobe epilepsy. Arch. Neurol. 10:1964;233-248.
4. Bruton C.J. The neuropathology of temporal lobe epilepsy. 1988;Oxford Univ. Press, New York.
5. Sager H.J., Oxbury J.M. Hippocampal neuron loss in temporal lobe epilepsy: correlation with early childhood convulsions. Ann. Neurol. 22:1987;334-340.
6. Cendes F., Andermann F., Dubeau F.et al. Early childhood prolonged febrile convulsions, atrophy and sclerosis of mesial structures, and temporal lobe epilepsy: an MRI volumetric study. Neurology. 43:1993;1083-1087.
7. Tasch E., Cendes F., Li L.M., Dubeau F., Andermann F., Arnold D.L. Neuroimaging evidence of progressive neuronal loss and dysfunction in temporal lobe epilepsy. Ann. Neurol. 45:1999;569-576.
8. Theodore W.H., Bhatia S., Hatta J.et al. Hippocampal atrophy, epilepsy duration, and febrile seizures in patients with partial seizures. Neurology. 52:1999;132-136.
9. Davies K.G., Hermann B.P., Dohan F.C., Foley K.T., Bush A.J., Wyler A.R. Relationship of hippocampal sclerosis to duration and age of onset of epilepsy, and childhood febrile seizures in temporal lobectomy patients. Epilepsy Res. 24:1996;119-126.
10. Cendes F., Andermann F., Gloor P.et al. Atrophy of mesial structures in patients with temporal lobe epilepsy: cause or consequence of repeated seizures? Ann. Neurol. 34:1993;795-801.
11. Trenerry M.R., Jack C.R., Sharbrough F.W.et al. Quantitative MRI hippocampal volumes: association with onset and duration of epilepsy, and febrile convulsions in temporal lobectomy patients. Epilepsy Res. 15:1993;247-252.
12. Farrell P.J., Balkow K., Hunt T., Jackson R.J., Trachsel H. Phosphorylation of initiation factor eIF-2 and the control of reticulocyte protein synthesis. Cell. 11:1977;187-200.
13. Rowlands A.G., Montine K.S., Henshaw E.C., Panniers R. The catalytic mechanism of guanine nucleotide exchange factor action and competitive inhibition by phosphorylated eukaryotic initiation factor 2. J. Biol. Chem. 263:1988;5526-5533.
14. DeGracia D.J., Sullivan J.M., Neumar R.W., Alousi S.S., Hikade K.R., Pittman J.E.et al. Effect of brain ischemia and reperfusion on the localization of phosphorylated eukaryotic initiation factor 2 alpha. J. Cereb. Blood Flow Metab. 17:1997;1291-1302.
15. Goldstein E.N., Owen C., White B.C., Rafols J.A. Ultrastructural localization of phosphorylated eIF2alpha (eIF2alphaP) in rat dorsal hippocampus during reperfusion. Acta Neuropathol. 98:1999;493-505.
16. Petrov T., Underwood B., Alousi S., Owen S., Rafols J.A. Upregulation of iNOS and eIF-2α(P) expression is paralleled by suppression of protein synthesis in the hypothalamus following trauma to the brain. J. Neurotrauma. 98:2001;799-812.
17. Rafols J.A., White B.C., Francis T., Petrov T., Underwood B.D. Localization of phosphorylated eukaryotic initiation factor 2 alpha in hippocampus after traumatic brain injury. Soc. Neurosci. (Abstr.). 27(1):2001;568.
18. Kumar R., Azam S., Sullivan J.M., Owen C., Cavener D.R., Zhang P.et al. Brain ischemia and reperfusion activate the eukaryotic initiation factor 2alpha kinase, PERK. J. Neurochem. 77:2001;1418-1421.
19. Atkins C.M., Sweatt J.D. Reactive oxygen species mediate activity-dependent neuron-glia signaling in output fibers of the hippocampus. J. Neurosci. 9:1999;7241-7248.
20. Floyd R.A. Antioxidants, oxidative stress, and degenerative neurological disorders. Proc. Soc. Exp. Med. 222:1999;236-245.
21. Kim Y.M., Son K., Hong S.J., Green A., Chen J.J., Tzeng E.et al. Inhibition of protein synthesis by nitric oxide correlates with cytostatic activity: nitric oxide induces phosphorylation of initiation factor eIF-2 alpha. Mol. Med. 4:1998;179-190.
22. Doyle C.A., Slater P. Localization of neuronal and endothelial nitric oxide synthase isoforms in human hippocampus. Neuroscience. 76:1997;387-395.
23. Downen M., Zhao M.L., Lee P., Weidenheim K.M., Dickson D.W., Lee S.C. Neuronal nitric oxide synthase expression in developing and adult human CNS. J. Neuropathol. Exp. Neurol. 58:1999;12-21.
24. Norris P.J., Faull R.L., Emson P.C. Neuronal nitric oxide synthase (nNOS) mRNA expression and NADPH-diaphorase staining in the frontal cortex, visual cortex and hippocampus of control and Alzheimer's disease brains. Mol. Brain Res. 41:1996;36-49.
25. Ferrante R.J., Kowall N.W., Beal M.F., Richardson E.P. Jr., Bird E.D., Martin J.B. Selective sparing of a class of striatal neurons in Huntington's disease. Science. 230:1985;561-563.
26. Watson C., Andermann F., Gloor P.et al. Anatomic basis of amygdaloid and hippocampal volume measurement by magnetic resonance imaging. Neurology. 42:1992;1743-1750.
27. Watson C., Jack C.R., Cendes F. Volumetric magnetic resonance imaging: clinical applications and contributions to the understanding of temporal lobe epilepsy. Arch. Neurol. 54:1997;1521-1531.
28. Watson C., Cendes F., Fuerst D.et al. Specificity of volumetric magnetic resonance imaging in detecting hippocampal sclerosis. Arch. Neurol. 54:1997;67-73.
29. Watson C., Nielsen S.L., Cobb C., Burgerman R., Williamson B. Pathological grading system for hippocampal sclerosis: correlation with magnetic resonance imaging-based volume measurements of the hippocampus. J. Epilepsy. 9:1996;56-64.
30. Wyler A.R., Dohan F.C., Schweitzer J.B., Berry A.D. A grading system for mesial temporal pathology (hippocampal sclerosis) from anterior temporal lobectomy. J. Epilepsy. 5:1992;220-225.
31. Petrov T., Harris K.H., McTavish D., Krukoff T.L., Jhamandas J.H. Hypotension induces c-fos expression in NADPH-diaphorase positive hypothalamic neurons. Neuropharmacology. 34:1995;509-514.
32. Jhamandas J.H., Harris K.H., Petrov T., Jhamandas K.H. Activation of nitric oxide synthesizing neurons during precipitated morphine withdrawal. NeuroReport. 7:1996;2843-2846.
33. Hope B.T., Michael G.J., Knigge K.M., Vincent S.R. Neuronal NADPH diaphorase is a nitric oxide synthase. Proc. Natl. Acad. Sci. U. S. A. 88:1991;2811-2814.
34. Falconer M.A., Cavanagh J.B. Clinico-pathological considerations of temporal lobe epilepsy due to small focal lesions. Brain. 82:1959;404-483.
35. deLamerolle N.C., Sloviter R.S., Kim J.H., Robbins R.J., Spencer D.D. Evidence for hippocampal interneuron loss in human temporal lobe epilepsy. Epilepsia. 29:1988;674.
36. deLamerolle N.C., Kim J.H., Robbins R.J., Spencer D.D. Hippocampal interneuron loss and plasticity in human temporal lobe epilepsy. Brain Res. 495:1989;387-395.
37. Robbins R.J., Brines M.L., Kim J.H., Adrian T., deLamerolle N.C., Welsh S.et al. A selective loss of somatostatin in the hippocampus of patients with temporal lobe epilepsy. Ann. Neurol. 29:1992;325-332.
38. Mathern G.W., Babb T.L., Pretorius J.K., Leite J.P. Reactive synaptogenesis and neuron densities for neuropeptide Y, somato-statin, and glutamate decarboxylase immunoreactivity in the epileptogenic human fascia dentata. J. Neurosci. 15:1995;3990-4004.
39. Babb T.L., Kupfer W.R., Pretorius J.K., Crandall P.H., Lavesque M.F. Synaptic reorganization by mossy fibers in human epileptic fascia dentata. Neuroscience. 42:1991;351-364.
40. Houser C.R., Miyashiro J.E., Swartz B.E., Walsh G.O., Rich J.R., Delgado-Escueta A.V. Altered patterns of dynorphin immunoreactivity suggest mossy fiber reorganization in human hippocampal epilepsy. J. Neurosci. 10:1990;267-282.
41. Mathern G.W., Pretorius J.K., Babb T.L. Quantified patterns of mossy fiber sprouting and neuron densities in hippocampal and lesional seizures. J. Neurosurg. 82:1995;211-219.
42. Sutula T., Cascino G., Cavazos J., Parada I., Ramirez L. Mossy fiber synaptic reorganization in the epileptic human temporal lobe. Ann. Neurol. 26:1989;321-330.
43. deLamerolle N.C., Eid T., vonCampe G.et al. Glutamate receptor subunits GluR2 and GluR2/3 distribution shows reorganization in the human epileptogenic hippocampus. Eur. J. Neurosci. 10:1998;1687-1703.
44. Mathern G.W., Pretorius J.K., Mendoza D.et al. Increased hippocampal AMPA and NMDA receptor subunit immunoreactivity in temporal lobe epilepsy patients. J. Neuropathol. Exp. Neurol. 57:1998;615-634.
45. McNamara J.O. Cellular and molecular basis of epilepsy. J. Neurosci. 14:1994;3413-3425.
46. Sloviter R.S. The functional organization of the hippocampal dentate gyrus and its relevance to the pathogenesis of temporal lobe epilepsy. Ann. Neurol. 35:1994;640-654.
47. Johansen F.F., Zimmer J., Diemer N.H. Early loss of somatostatin neurons in dentate hilus after cerebral ischemia in the rat precedes CA1 pyramidal cell loss. Acta Neuropathol. 73:1987;110-114.
48. Lowenstein D.H., Thomas M.J., Smith D.H., McIntosh T.K. Selective vulnerability of dentate hilar neurons following traumatic brain injury: a potential mechanistic link between head trauma and disorders of the hippocampus. J. Neurosci. 12:1992;4846-4853.
49. White B.C., Sullivan J.M., DeGracia D.J., O'Neil B.J., Neumar R.W., Grossman L.I.et al. Brain ischemia and reperfusion: molecular mechanisms of neuronal injury. J. Neurol. Sci. 179:2000;1-33.
50. Rafols J.A., Daya A.M., O'Neil B.J., Krause G.S., Neumar R.W., White B.C. Global brain ischemia and reperfusion: Golgi apparatus ultrastructure in neurons selectively vulnerable to death. Acta Neuropathol. 90:1995;17-30.
51. Rafols J.A., Alousi S.S., Owen C.R., White B.C., Sullivan J.M. High doses of insulin do not prevent dephosphorylation of eIF2αP, recovery of protein synthesis, and atrophy of hippocampal CA3 neurons during reperfusion. J. Cereb. Blood Flow Metab. 19(Suppl. 1):1999;S511.
52. Underwood BD, Francis T, Owen CR, Miller JM, Gryzbowski M, McAllister JP, et al. Traumatic brain injury induces biphasic phosphorylation of the alpha subunit of eukaryotic initiation factor 2 (eIF2alpha) in cortical neurons: the second phase follows cytoplasmic release of cytochrome c. J Neurotrauma (in press).
53. Srivastava S.P., Kumar K.U., Kaufman R.J. Phosphorylation of eukaryotic translation initiation factor 2 mediates apoptosis in response to activation of the double-stranded RNA-dependent protein kinase. J. Biol. Chem. 273:1998;2416-2423.
54. McNaught K.S.P., Brown G.C. Nitric oxide causes glutamate release from brain synaptosomes. J. Neurochem. 70:1998;1541-1546.
55. Yasuda H., Fujii M., Fujisawa H., Ito H., Suzuki M. Changes in nitric oxide synthesis and epileptic activity in the contralateral hippocampus of rats following intrahippocampal kainate injection. Epilepsia. 42:2001;13-20.